Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-08-04 16:05:14 ET · period of report 2026-08-03 · accession 0001468316-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-04 16:05 | 2026-08-03 | FENC | Raykov Rosty | Former Dir | S - Sale | $9.58 | -10.0K | 131.6K | -7% | -$95.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-08-03 | S | D | 10,000 | $9.58 | 131,633 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025. |